|
MechanismHemoglobins modulators |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.NG |
First Approval Date06 Jul 2006 |
|
MechanismCAPN1 inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismCalpain1/2 inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Xechem International, Inc.
0 Patents (Medical) associated with Xechem International, Inc.
100 Deals associated with Xechem International, Inc.
100 Translational Medicine associated with Xechem International, Inc.